Health Information Index

A   B   C   D  E   F   G   H   I   J   K   L   M   N  O   P   Q  R   S   T   U  V   W  X  Y  Z  En Español

Order a Publication

Most Requested Health Publications:

Understanding Pompe Disease

Pompe (POM-pay) disease, also known as glycogen storage disease type II or acid maltase deficiency, is a rare genetic disorder that results in profound muscle weakness. The disease is caused by mutations in the gene that instructs the body to make an enzyme called acid alpha-glucosidase (GAA). Normally, the body uses this enzyme to break down glycogen (stored sugar) into glucose (sugar). But in Pompe disease, GAA is absent or significantly reduced, causing excessive amounts of glycogen to accumulate in the body’s tissues, which results in major damage. The heart and skeletal muscles are most affected. Read more about Pompe disease... Photo of Dr. Raben and others reviewing microscope slides.

American Recovery and Reinvestment Act (ARRA)

Recovery act icon

NIAMS is grateful for the opportunity afforded by the American Recovery and Reinvestment Act to further our mission to invest in vital biomedical research related to diseases affecting the bones, joints, muscles and skin. NIH is well positioned to fund the best science in pursuit of improving the length and the quality of the lives of our citizens, while at the same time stimulating the economy. Read more about NIAMS plans for the American Recovery and Reinvestment Act.

NIAMS is featuring ARRA success stories from across the country. Visit NIAMS ARRA Chronicles to read more about other communities that have benefited.

We also want to hear directly from you. Share your ARRA story and share your success with Congress, the administration, the public and your colleagues. This is an excellent opportunity for you to highlight your science and tell us how ARRA has benefited your work. Tell us your success stories!

 

In the News

 

More News